Newswise — Houston, Texas and Johannesburg, South Africa – July 28, 2026 – IntelliGenome, Inc., a biotechnology company developing CRISPR-based molecular diagnostics, today announced the appointment of ILEX South Africa (Pty) Ltd. as its exclusive distributor for CRISPR-TB® in South Africa. "South Africa has consistently led the world in tuberculosis research and innovation," said Kurt Wehrle, Vice President, Partnerships & Strategic Alliances at IntelliGenome. "We are pleased to partner with IntelliGenome to help advance blood-based tuberculosis diagnostics in South Africa," said Shameera August, Chief Executive Officer of ILEX South Africa. "We look forward to working with clinicians, researchers, and healthcare institutions to expand access to CRISPR-TB throughout South Africa." About ILEX South AfricaILEX South Africa (Pty) Ltd., established in 1992, is one of Africa's leading providers of in vitro diagnostics (IVD), molecular diagnostics, and laboratory solutions.